Details
Category: Volume 05 Issue 09 September 2017
Hits: 1805

Title: Use & Significance of Anti CCP in RA & Seronegative RF Patients

Authors: Dr D.Ayisha M.D, Dr Eunice Swarna Jacob M.D, Dr P.Shanmugapriya M.D

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i9.07

Abstract

Rheumatoid Arthritis (RA) is the most common systemic inflammatory, auto immune Rheumatic disease. Although the precise aetiology of RA remains unknown1, there is strong evidence for autoimmunity, 6 The aim of the present study  is to evaluate the use and significance of Anti CCP antibodies in Rheumatoid Arthritis with RF positive & in RF Sero Negative Rheumatoid Arthritis(early synovitis) and the Healthy Blood Donors as control. In this study a total number of 150 patients (each group50) including both males and females were studied. Anti-CCP was positive in 39 of 50 RA patients (78%), 14 of 50 (28%)  Early Synovitis cases & no HBD were positive for Anti CCP. RF was positive in38 of 50 RA patients, 21 of 50 ES patients & 4 of 50 healthy blood donors. Sensitivity of RF Test in RA is 76% & Specificity is 92%. Sensitivity of Anti CCP test in RA is 78% & Specificity is 100%. Anti CCP Test in Sero Negative RA patients (6 out of 12) is 50%. Being a specific marker in advanced RA, the Anti CCP antibody in ES is a very important predictor. So Anti CCP has the hallmark of establishing as a diagnostic tool, early predictor and provides additive sensitivity to RF. The presence of both in serum is a strong indicator of RA. So it should also be included among the diagnostic criteria of RA along with RF. and as a prognostic indicator in RA patients on treatment.  

Key Words: Anti CCP, RA, Early Synovitis.

References

  1. Gerard A. Schellekens, Ben A.W. de Jong, Frank H.J. van den Hoogen et al.Citrulline is an Essential Constituent of Antigenic Determinants Rheumatoid Arthritis–specific Autoantibodies. January 1998; Volume 101 (Number 1):273 –281.
  2. Thomas Skogh.Does a positive anti-CCP test identify a distinct arthritis entity?Arthritis  Research &Therapy, December 2005;  Vol 7 (No 6) : 121.
  3. Kunihiro Nishimura, MD,MPH; MS; Daisuke Sugiyama, MD,MPH;Yoshinori Kogata et al.Annals of Internal Medicine Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis. American College of Physicians, 2007; 146: 797-808.
  4. Eric-jan j. A.Kroot,ben a.W.De jong et al.The prognostic value of  Anti– cyclic citrullinated peptide antibody in patients with recent – onset Rheumatoid   arthritis & Rheumatism. August 2000; vol. 43 no. 8: pp 1831–1835.
  5. bel altun,Reyhan calipkan,y.Al.oner et al.a new marker in  Rheumatoid Arthritis- autoimmunity relation: anti-cyclic citrullinated peptide antibody. Turk j  immunol; 2004; 9: 21-265.
  6. Pooja khosla,s Shankar,lalit duggal et al. Anti ccp antibodies in rheumatoid Arthritis. Rheumatol assoc.2004; 12 : 143 - 46.
  7. Martinus AM van Boekel, R Vossenaar, Frank HJ van den Hoogen et al.    autoantibody systems in rheumatoid arthritis: Specificity, sensitivity and diagn-ostic value Res, 2002; 4:87-93.
  8. Gerard a.Schellekens,hendrik visser,ben a.W.De jong et al.The diagnostic properties of rheumatoid arthritis   antibo-dies  recognizing a  cyclic citrullinated    Arthritis & Rheumatism,2000; vol. 43,no.1:  pp 155–156.
  9. By Anil Vasishta, Diagnosing early-onset rheumatoid Arthritis: The role of anti-CCP   antibodies,  American clinical  Aug-Sep - 2002;
  10. RDLCyclic Citrullinated Peptide,CCP: A New Serum Markers for Rheumatoid Arthritis, Updated  September 4; 2007.
  11. Nehir samanci, md. sebahat  ozdem, md;  Halide  akbas, et al. Diagnostic  value and  clinical significance of anti-ccp in patients with Advanced rheumatoid arthritis. journal national  medical association, August, 2005;(vol.97) no. 8:
  12. vanAken,J.H.M.vanBilsen,C.F.Allaart, T.W.J.Huizinga, F.C.Breedveldet al.The Leiden Early Arthritis Clinic,Clin Exp Rheumatol 2003; 21 (Sup31): S100-S105.
  13. FA van Gaalen,SP Linn-Rasker,WJ van Venrooij et al. Autoantibodies predict progression to Rheumatoid arthritis in  undifferentiated arthritis. The Netherlands  Arthritis Res  Ther,  2003; 5( suppl1):28.
  14. L.E.Ribeiro H.L.A. Pereira,N.P. Silva,et al. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involve-ment. Braz J Med Biol  2008; Res 41.
  15. The American Association  for  Clinical  Papers  in  Press  doi:    10.2004; 1373/ clinche
  16. J.W.Zendman,W.J.vanVenrooij and G.J.M. Pruijn et al,Use and significance of  anti-CCP autoantibodies  in rheumatoid arthritis. Rheumatology; 2006,   45:20–25.
  17. Ger J.M. Pruijn,Erik R.Vossenaar,Jan WDrijfhout, Walther J. van Venrooij etal. Anti-CCP Antibody Detection Facilitates Early Diagnosis and  Prognosis of Rheum-atoid Arthritis. Current Rheumatology Reviews,2005;1, 1-7 1.
  18. Very early‘Rheumatoid’arthritis cohorts: limited by selection, Oxford University Press  on  behalf   of  the  British  Society  for  Rheumatology; 
  19. P.Machold1,V.P.K. Nell1,T.A.Stamm et al, The Austrian Early Arthritis  Registry. Clin Exp  Rheumatol;  2003, 21  (Suppl. 31): S113 - S117.
  20. Anti - citrullinated protein antibody, Wikipedia.
  21. CT Chou1HT Liao2,CH Chen et al,The Clinical Application of Anti- CCP in Rheumatoid Arthritis and Other Rheumatic Diseases Biomarker  Insights: 2007; 2 :165 – 171.
  22. Shadick,MD,MPH;NancyR.Cook,ScD;ElizabethW.Karlson,MD et al,C - reactive Protein in the Prediction  of   Rheumatoid Arthritis  in  Women.  Arch Intern  Med.  2006; 166 : 2490-2494.           
  23. The Predictive Power of Anti-Cyclic Citrullinated Peptide Antibodies: Window into Understanding Gene / Environment / Immunity Interactions, 2006,  The  Journal  of   Rheumatology;  33:7.
  24. Ulrich sauerland, heidemarie Becker, matthias seidel et al.  Clinical utility of  the  anti-CCP assay   experiences  with  700  patients  N.Y.  acad. Sci. 2005; 1050: 314–318.
  25. Münevver serdarofluhaoim çakârbay orhan defer   et al,  the association of  anti-ccp antibodies  with disease activity   in  rheumatoid   Rheumatol   int, 2008 ;  28:  965–970.

Corresponding Author

Dr D.Ayisha M.D

Senior Assistant Professor, Department of Microbiology,

Thanjavur Medical College, Thanjavur Tamilnadu